title: Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
abstract: The aim of the present Monte Carlo study is to evaluate the variation of energy deposition in healthy tissues in the human eye which is irradiated by brachytherapy sources in comparison with the resultant dose increase in the gold nanoparticle (GNP)-loaded choroidal melanoma. The effects of these nanoparticles on normal tissues are compared between 103Pd and 125I as two ophthalmic brachytherapy sources. Dose distribution in the tumor and healthy tissues has been taken into account for both brachytherapy sources. Also, in certain points of the eye, the ratio of the absorbed dose by the normal tissue in the presence of GNPs to the absorbed dose by the same point in the absence of GNPs has been calculated. In addition, differences of the absorbed dose in the tumor observed in the comparison of simple water phantom and actual simulated human eye in presence of GNPs are also a matter of interest that have been considered in the present work. The difference between the eye globe and the water phantom is more obvious for 125I than that of the 103Pd when the ophthalmic dosimetry is done in the presence of GNPs. Whenever these nanoparticles are utilized in enhancing the absorbed dose by the tumor, the use of 125I brachytherapy source will greatly amplify the amount of dose enhancement factor (DEF) in the tumor site without inflicting much dam-age to healthy organs, when compared to the 103Pd source. For instance, in the concentration of 30 mg GNPs, the difference amongst the calculated DEF for 125I between these phantoms is 5.3%, while it is 2.45% for 103Pd. Furthermore, in Monte Carlo studies of eye brachytherapy, more precise definition of the eye phantom instead of a water phantom will become increasingly important when we use 125I as opposed to 103Pd.
authors.affiliation: K.N. Toosi University of Technology. s_asadi@sina.kntu.ac.ir.
authors.forename: Somayeh
authors.initials: S
authors.lastname: Asadi
authors.forename: Mehdi
authors.initials: M
authors.lastname: Vaez-Zadeh
authors.forename: Mohammad
authors.initials: M
authors.lastname: Vahidian
authors.forename: Mahdieh
authors.initials: M
authors.lastname: Marghchouei
authors.forename: S Farhad
authors.initials: SF
authors.lastname: Masoudi
mesh_terms: D000328:Adult; D001918:Brachytherapy / Q000295:instrumentation*; D003198:Computer Simulation; D005134:Eye Neoplasms / Q000532:radiotherapy*; D006046:Gold / Q000737:chemistry*; D006801:Humans; D007457:Iodine Radioisotopes; D008545:Melanoma / Q000532:radiotherapy*; D053768:Metal Nanoparticles / Q000737:chemistry*; D009010:Monte Carlo Method; D058958:Organs at Risk / Q000528:radiation effects; D010165:Palladium; D019047:Phantoms, Imaging; D011874:Radiometry; D011879:Radiotherapy Dosage; D014867:Water
chemical_list: D007457:Iodine Radioisotopes; D014867:Water; D010165:Palladium; D006046:Gold